Graham Carpenter mainly focuses on Cell biology, Epidermal growth factor, Biochemistry, Receptor and Tyrosine kinase. The various areas that Graham Carpenter examines in his Cell biology study include ROR1, Transmembrane protein and Mechanism of action. His Epidermal growth factor research incorporates themes from Cell surface receptor, Endocrinology and In vitro.
His research investigates the connection between Receptor and topics such as Cell that intersect with problems in Intracellular. Graham Carpenter has researched Tyrosine kinase in several fields, including Molecular biology, Receptor tyrosine kinase, Phosphorylation and Platelet-derived growth factor receptor. His biological study spans a wide range of topics, including Tyrosine and Phospholipase C.
His primary scientific interests are in Cell biology, Epidermal growth factor, Biochemistry, Molecular biology and Receptor. His study in Receptor tyrosine kinase, Phosphorylation, Growth factor receptor, Signal transduction and Growth factor receptor inhibitor are all subfields of Cell biology. His studies deal with areas such as Protein tyrosine phosphatase, Tyrosine kinase, Proto-oncogene tyrosine-protein kinase Src and ROR1, Platelet-derived growth factor receptor as well as Receptor tyrosine kinase.
Graham Carpenter focuses mostly in the field of Epidermal growth factor, narrowing it down to matters related to Endocrinology and, in some cases, Cell culture. Graham Carpenter combines subjects such as Cell, Glycosylation and Cell growth with his study of Receptor. His study in Phospholipase C is interdisciplinary in nature, drawing from both Phospholipase and Second messenger system.
Graham Carpenter spends much of his time researching Cell biology, Receptor tyrosine kinase, Molecular biology, ErbB and Biochemistry. His Cell biology research includes themes of Receptor and Epidermal growth factor. As a part of the same scientific study, he usually deals with the Epidermal growth factor, concentrating on Growth factor and frequently concerns with Phospholipase C activation.
His Receptor tyrosine kinase research integrates issues from Cell, Tyrosine kinase, Proto-oncogene tyrosine-protein kinase Src and ROR1, Platelet-derived growth factor receptor. Graham Carpenter has included themes like Ionomycin, Mitogen-activated protein kinase kinase and Kinase activity in his Molecular biology study. Graham Carpenter interconnects Regulation of gene expression, Kinase, Ectodomain and Neuregulin in the investigation of issues within ErbB.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epidermal growth factor.
G Carpenter;S Cohen.
Journal of Biological Chemistry (1972)
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.
Graham Carpenter;Stanley Cohen.
Journal of Cell Biology (1976)
Receptors for epidermal growth factor and other polypeptide mitogens.
Annual Review of Biochemistry (1987)
γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase
Chang-Yuan Ni;M. Paul Murphy;Todd E. Golde;Graham Carpenter.
Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.
S Nishibe;MI Wahl;SM Hernandez-Sotomayor;NK Tonks.
Human epidermal growth factor: isolation and chemical and biological properties
Stanley Cohen;Graham Carpenter.
Proceedings of the National Academy of Sciences of the United States of America (1975)
Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts.
G Carpenter;K J Lembach;M M Morrison;S Cohen.
Journal of Biological Chemistry (1975)
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro.
Graham Carpenter;Lloyd King;Stanley Cohen.
Human epidermal growth factor and the proliferation of human fibroblasts.
Graham Carpenter;Stanley Cohen.
Journal of Cellular Physiology (1976)
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.
Shizhen Emily Wang;Archana Narasanna;Marianela Perez-Torres;Bin Xiang.
Cancer Cell (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: